Comparison between the recovery time of alfentanil and fentanyl in balanced propofol sedation for gastrointestinal and colonoscopy: a prospective, randomized study
Abstract:BackgroundThere is increasing interest in balanced propofol sedation (BPS) titrated to moderate sedation (conscious sedation) for endoscopic procedures. However, few controlled studies on BPS targeted to deep sedation for diagnostic endoscopy were found. Alfentanil, a rapid and short-acting synthetic analog of fentanyl, appears to offer clinically significant advantages over fentanyl during outpatient anesthesia.It is reasonable to hypothesize that low dose of alfentanil used in BPS might also result in more r… Show more
“…Toklu et al [7] compared remifentanil + propofol and remifentanil + etomidate in patients who underwent colonoscopy under sedation and reported that the mean discharge times were 32.8 and 24.6 minutes, respectively. The mean discharge time in our study was approximately 15 minutes (15.1 vs 15.7 minutes) in both groups, which was similar to the studies that showed that the mean discharge times were around 15 minutes using moderate sedation for colonoscopy [8][9][10].…”
Section: Discussionsupporting
confidence: 90%
“…It is believed that pain, distension of colon, stretching of the mesentery, and sedation regimen provoke these symptoms [1][2][3][4][5][6][7][8][9][10]. In our study, no vasovagal reactions were observed in any patients.…”
Section: Discussioncontrasting
confidence: 62%
“…Although several trials have been performed using different anesthetic agents, the optimal combination has not yet been established [3][4][5][6][7][8][9]. In addition, some patients may require much deeper sedation with higher doses leading to cardiorespiratory depression, loss of protective reflexes, and delayed discharge [10,11].…”
“…Toklu et al [7] compared remifentanil + propofol and remifentanil + etomidate in patients who underwent colonoscopy under sedation and reported that the mean discharge times were 32.8 and 24.6 minutes, respectively. The mean discharge time in our study was approximately 15 minutes (15.1 vs 15.7 minutes) in both groups, which was similar to the studies that showed that the mean discharge times were around 15 minutes using moderate sedation for colonoscopy [8][9][10].…”
Section: Discussionsupporting
confidence: 90%
“…It is believed that pain, distension of colon, stretching of the mesentery, and sedation regimen provoke these symptoms [1][2][3][4][5][6][7][8][9][10]. In our study, no vasovagal reactions were observed in any patients.…”
Section: Discussioncontrasting
confidence: 62%
“…Although several trials have been performed using different anesthetic agents, the optimal combination has not yet been established [3][4][5][6][7][8][9]. In addition, some patients may require much deeper sedation with higher doses leading to cardiorespiratory depression, loss of protective reflexes, and delayed discharge [10,11].…”
“…1992, Engelhard et al . 1999 ).This so-called "admixture" is commonly used in humans for sedation (Ho et al . 2012 ), although it is not free of complications and may cause respiratory depression (Yoon et al .…”
1Corresponding author email: Filippo.Montefiori@ed.ac.uk O BJECTIVES : To evaluate sedation quality and cardiorespiratory variables in dogs sedated using a targetcontrolled infusion of propofol or propofol-alfentanil admixture.M ETHODS : A total of 60 dogs undergoing diagnostic imaging were randomly assigned to one of three sedation protocols: propofol alone; propofol with a low concentration of 12 µg of alfentanil per mL of propofol; or propofol with a higher concentration of 24 µg of alfentanil per mL of propofol. Targetcontrolled infusion was initiated at a propofol target concentration of 1·5 µg/mL and increased until lateral recumbency was achieved. Times to adopt lateral recumbency and recover, pulse rate, respiratory rate, oscillometric mean arterial pressure and oxygen saturation were recorded. Quality of sedation onset and recovery were scored. R ESULTS : Propofol target at lateral recumbency differed significantly (P=0·01) between groups with median (range) values of 3·0 (1·5 to 5·5), 2·0 (2 to 4·5) and 2·25 (1·5 to 3·5) µg/ mL for propofol alone, propofol with the lower concentration of alfentanil and propofol with the higher concentration of alfentanil groups, respectively. Time to lateral recumbency was longer and quality of onset less smooth for the propofol group. Pulse rate change differed significantly (P<0·001) between groups (mean pulse rate change at onset of sedation: propofol group +2 ±24 bpm, low concentration alfentanil group −30 ±24 bpm, higher concentration alfentanil group −26 ±23 bpm). Hypoxaemia ( SpO 2 <90%) occurred in 1, 3 and 13 dogs, in the propofol group, the low concentration alfentanil group and the higher concentration of alfentanil group, respectively (P<0·001).C LINICAL S IGNIFICANCE : Addition of alfentanil to propofol target-controlled infusion did not confer cardiovascular benefits and, at the higher concentration, alfentanil increased the incidence of hypoxaemia.F. Montefi ori ' s current address is Department of Veterinary Anaesthesia, Royal (Dick) School of Veterinary Studies, Easter Bush Campus Midlothian EH25 9RG, Edinburgh
“…These advantages make it an attractive analgesic supplement for short ambulatory surgical procedures [13,14]. Clinically, analgesia with propofol-alfentanil combination has been widely used in short surgical procedures [15][16][17] such as arthroscopy, bunionectomy, esophagogastroduodenoscopy, lithotripsy and ureteroscopy. Fospropofol produces a predictable pharmacokinetic and pharmacodynamic profile by delivering controlled sedation in an outpatient setting.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.